Simplex Trading’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-24,000
| Closed | -$7.6M | – | 10251 |
|
|
2023
Q4 | $7.6M | Buy |
24,000
+11,600
| +94% | +$2.25M | ﹤0.01% | 1272 |
|
|
2023
Q3 | $2.1M | Sell |
12,400
-2,000
| -14% | -$376K | ﹤0.01% | 2031 |
|
|
2023
Q2 | $3.12M | Buy |
14,400
+2,900
| +25% | +$621K | ﹤0.01% | 1632 |
|
|
2023
Q1 | $2.09M | Sell |
11,500
-5,700
| -33% | -$1.09M | ﹤0.01% | 1920 |
|
|
2022
Q4 | $3.38M | Buy |
17,200
+12,300
| +251% | +$2.64M | ﹤0.01% | 1474 |
|
|
2022
Q3 | $1.1M | Sell |
4,900
-13,500
| -73% | -$2.73M | ﹤0.01% | 2547 |
|
|
2022
Q2 | $2.33M | Buy |
18,400
+6,200
| +51% | +$713K | ﹤0.01% | 1718 |
|
|
2022
Q1 | $1.55M | Buy |
12,200
+12,000
| +6,000% | +$1.35M | ﹤0.01% | 2375 |
|
|
2021
Q4 | $26K | Hold |
200
| – | – | ﹤0.01% | 8095 |
|
|
2021
Q3 | $24K | Hold |
200
| – | – | ﹤0.01% | 8296 |
|
|
2021
Q2 | $22K | Buy |
200
+196
| +4,900% | +$22.9K | ﹤0.01% | 8513 |
|
|
2021
Q1 | $48K | Buy |
+4
| New | +$453 | ﹤0.01% | 6679 |
|
|
2020
Q2 | – | Sell |
-55
| Closed | -$396K | – | 8574 |
|
|
2020
Q1 | $396K | Buy |
+55
| New | +$4.7K | ﹤0.01% | 2839 |
|
Simplex Trading's KRTX Position: Q1 2024 in Review
Simplex Trading sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 4,574 shares — an estimated $1.45M sold.
Simplex Trading first reported a position in KRTX in Q1 2020 and held it in 8 quarters. The position peaked at $1.59M in Q3 2022. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.
- Simplex Trading reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
- Simplex Trading sold 4,574 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $1.45M.
- Simplex Trading first reported a position in Karuna Therapeutics, Inc. Common Stock in Q1 2020 and held it in 8 quarters.
- Simplex Trading's Karuna Therapeutics, Inc. Common Stock position peaked at $1.59M in Q3 2022.
- 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.
Based on Simplex Trading's 13F filing for Q1 2024, filed 25 Apr 2024.